Detalhe da pesquisa
1.
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis.
bioRxiv
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464251
2.
Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance.
Nat Commun
; 14(1): 5253, 2023 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37644036
3.
Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1.
Cell Rep
; 39(11): 110971, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705030
4.
Counter Regulation of Spic by NF-κB and STAT Signaling Controls Inflammation and Iron Metabolism in Macrophages.
Cell Rep
; 31(13): 107825, 2020 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32610126
5.
CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation.
Cancer Discov
; 9(11): 1538-1555, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31466944